Skip to content
HowShorted

ABEONA THERAPEUTICS INC. short interest in 2021

In 2021, ABEONA THERAPEUTICS INC.'s disclosed short interest ran from 1.72% of shares outstanding on 15 Jan 2021 to 1.28% on 31 Dec 2021, a change of -0.44 percentage points. The year's high was 7.88% on 14 May 2021 and its low 0.89% on 30 Nov 2021, averaging 3.93% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.05 days on 13 Aug 2021. Full history: ABEONA THERAPEUTICS INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ABEONA THERAPEUTICS INC. in 2021

2021 in figures

Start of year
1.72% (15 Jan 2021)
End of year
1.28% (31 Dec 2021)
Change
-0.44 pp
High
7.88% (14 May 2021)
Low
0.89% (30 Nov 2021)
Average
3.93%
Highest days to cover
8.05 (13 Aug 2021)
SEC filings marked
9

Every report in 2021

ABEONA THERAPEUTICS INC. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20211.72%1.00
29 Jan 20212.92%1.00
12 Feb 20213.00%1.00
26 Feb 20213.46%1.00
15 Mar 20215.86%2.14
31 Mar 20214.94%2.9610-K filed, results (8-K)
15 Apr 20216.19%5.10
30 Apr 20216.32%5.09
14 May 20217.88%3.20
28 May 20216.73%5.4310-Q filed, results (8-K), results (8-K)
15 Jun 20216.29%4.56
30 Jun 20214.13%2.11
15 Jul 20214.83%5.69
30 Jul 20214.66%2.3710-Q filed, results (8-K)
13 Aug 20214.54%8.05
31 Aug 20213.71%7.15
15 Sep 20213.20%6.69
30 Sep 20212.81%5.81
15 Oct 20212.87%2.99
29 Oct 20212.63%3.96
15 Nov 20212.07%2.3810-Q filed, results (8-K)
30 Nov 20210.89%1.00
15 Dec 20211.32%1.57
31 Dec 20211.28%1.00

See also: ABEONA THERAPEUTICS INC.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.